NCT06003933

Brief Summary

The inter-semispinal plane (ISP) block is a novel ultrasound-guided technique that involves local anesthetic injection into the fascial plane between the semispinalis cervicis and semispinalis capitis muscles with subsequent block of the dorsal rami of the cervical spinal nerves and hence can get adequate postoperative analgesia. The authors hypothesized that ISP block can reduce the postoperative analgesic consumption in patients undergoing posterior cervical spine surgeries. The aim of this study is to evaluate the analgesic efficacy of ISP block in patients undergoing posterior cervical spine surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 3, 2023

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

August 15, 2023

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 15, 2023

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 22, 2023

Completed
19 days until next milestone

Study Completion

Last participant's last visit for all outcomes

September 10, 2023

Completed
Last Updated

September 13, 2023

Status Verified

September 1, 2023

Enrollment Period

6 months

First QC Date

August 15, 2023

Last Update Submit

September 12, 2023

Conditions

Keywords

inter-semispinal plane blockCervical spine surgeryPostoperative analgesia

Outcome Measures

Primary Outcomes (1)

  • postoperative rescue pethidine consumption

    in milligram

    48 hours after operation

Secondary Outcomes (10)

  • Postoperative visual analog pain score (VAS score)

    4 hours postoperatively

  • Postoperative visual analog pain score (VAS score)

    8 hours postoperatively

  • Postoperative visual analog pain score (VAS score)

    12 hours postoperatively

  • Postoperative visual analog pain score (VAS score)

    24 hours postoperatively

  • Postoperative visual analog pain score (VAS score)

    48 hours postoperatively

  • +5 more secondary outcomes

Other Outcomes (2)

  • Age

    1 hour preoperatively

  • body mass index

    1 hour preoperatively

Study Arms (2)

Control group

NO INTERVENTION

patients received general anesthesia only.

ISP group

EXPERIMENTAL

patients received bilateral ultrasound guided inter-semispinal plane (ISP) block at the level of C5 using 10 ml of 0.25% bupivacaine and 10ml xylocaine on each side to reduce the toxicity

Drug: Bupivacaine HydrochlorideDrug: Lidocaine HydrochlorideDevice: UltrasoundDevice: Needle

Interventions

10 ml of 0.25% bupivacaine on each side of cervical region at C5

Also known as: 0.25% bupivacaine HCL
ISP group

10ml xylocaine on each side of cervical region at C5

Also known as: Xylocaine
ISP group

The same anesthesiologist who is experienced in US guided regional anesthesia will perform the block.The five-layered posterior cervical muscles were identified at the level of C5 with a 6-15-MHz linear probe oriented in the transverse plane (SonoSite Edge, Bothell, Washington). The fifth cervical spine was counted from the C7 spinous process with the probe sliding cranially.

ISP group
NeedleDEVICE

the needle (22- G, 50-mm block needle (Visioplex, Vygon) was introduced in-plane through the skin and advanced into the fascial plane between the semispinalis cervicis and semispinalis capitis muscles. After negative aspiration for blood, 20 ml of bupivacaine 0.25% was injected5.

ISP group

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • American Society of Anesthesiologists (ASA) physical status I-II undergoing elective posterior cervical spine surgery

You may not qualify if:

  • Patient refusal
  • Patients with any contraindication to regional anesthesia (e.g. local infection, coagulation abnormality)
  • Known allergy to local anesthetics
  • Previous cervical disc surgery or fixation
  • Mental disorders
  • Drug or alcohol abuse.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fayoum University Hospital

Al Fayyum, Faiyum Governorate, 63514, Egypt

Location

Related Publications (3)

  • Kurd MF, Kreitz T, Schroeder G, Vaccaro AR. The Role of Multimodal Analgesia in Spine Surgery. J Am Acad Orthop Surg. 2017 Apr;25(4):260-268. doi: 10.5435/JAAOS-D-16-00049.

    PMID: 28291143BACKGROUND
  • Yayik AM, Cesur S, Ozturk F, Ahiskalioglu A, Ay AN, Celik EC, Karaavci NC. Postoperative Analgesic Efficacy of the Ultrasound-Guided Erector Spinae Plane Block in Patients Undergoing Lumbar Spinal Decompression Surgery: A Randomized Controlled Study. World Neurosurg. 2019 Jun;126:e779-e785. doi: 10.1016/j.wneu.2019.02.149. Epub 2019 Mar 8.

    PMID: 30853517BACKGROUND
  • Lumawig JM, Yamazaki A, Watanabe K. Dose-dependent inhibition of diclofenac sodium on posterior lumbar interbody fusion rates. Spine J. 2009 May;9(5):343-9. doi: 10.1016/j.spinee.2008.06.455. Epub 2008 Sep 14.

    PMID: 18790686BACKGROUND

MeSH Terms

Conditions

Pain, Postoperative

Interventions

BupivacaineLidocaineUltrasonographyNeedles

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

AnilidesAmidesOrganic ChemicalsAniline CompoundsAminesAcetanilidesDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisEquipment and Supplies

Study Officials

  • Mohamed A Shawky, MD

    Fayoum University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Patients were randomly allocated into either of the two groups using computer generated sequence and concealed in sealed opaque envelopes.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Lecturer of anesthesia

Study Record Dates

First Submitted

August 15, 2023

First Posted

August 22, 2023

Study Start

March 3, 2023

Primary Completion

August 15, 2023

Study Completion

September 10, 2023

Last Updated

September 13, 2023

Record last verified: 2023-09

Data Sharing

IPD Sharing
Will not share

Locations